Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
EPS (Diluted)
Takeda Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥112
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥96
|
CAGR 3-Years
39%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥224
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
Eisai Co Ltd
TSE:4523
|
EPS (Diluted)
¥158
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥197
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
8%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥20
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-7%
|
See Also
What is Takeda Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
112.4
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's EPS (Diluted) amounts to 112.4 JPY.
What is Takeda Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-5%
Over the last year, the EPS (Diluted) growth was -36%. The average annual EPS (Diluted) growth rates for Takeda Pharmaceutical Co Ltd have been -1% over the past three years , -4% over the past five years , and -5% over the past ten years .